Back to Search
Start Over
Technological advances towards extracellular vesicles mass production
- Source :
- Advanced Drug Delivery Reviews, Advanced Drug Delivery Reviews, Elsevier, 2021, 176, pp.113843. ⟨10.1016/j.addr.2021.113843⟩
- Publication Year :
- 2021
- Publisher :
- HAL CCSD, 2021.
-
Abstract
- Extracellular vesicles (EVs) are becoming essential actors in bio-therapeutics, as much for their regenerative or immunomodulatory properties as for their potential as cargo delivery vehicles. To enable the democratization of these EV-based therapies, many challenges remain such as large-scale production which is necessary to reduce costs of treatment. Herein, we review some advanced works on high-yield EV manufacturing. One approach consists in developing large-scale cell culture platforms, while others focus on cell stimulation to increase particle yield per cell. This can be done by moderate physico-chemical stresses or by disrupting cell membrane towards autoassembled vesicle-like particles. We critically compare these different techniques, keeping in mind that the field still lacks shared characterization standards, underline the importance of therapeutic potency assessment and discuss mass production strategies that have been identified in current clinical trials.
- Subjects :
- 0303 health sciences
Technology
[SDV]Life Sciences [q-bio]
Cell Membrane
Pharmaceutical Science
02 engineering and technology
021001 nanoscience & nanotechnology
Extracellular vesicles
03 medical and health sciences
Extracellular Vesicles
Drug Delivery Systems
Production (economics)
Animals
Humans
Cell stimulation
Business
Biochemical engineering
0210 nano-technology
ComputingMilieux_MISCELLANEOUS
030304 developmental biology
Subjects
Details
- Language :
- English
- ISSN :
- 0169409X
- Database :
- OpenAIRE
- Journal :
- Advanced Drug Delivery Reviews, Advanced Drug Delivery Reviews, Elsevier, 2021, 176, pp.113843. ⟨10.1016/j.addr.2021.113843⟩
- Accession number :
- edsair.doi.dedup.....30ff47847cafcafe65eba4963c4f6662